The 25 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 90.10, with a high estimate of 116.00 and a low estimate of 71.00. The median estimate represents a +14.07% increase from the last price of 78.99.
The current consensus among 32 polled investment analysts is to Hold stock in Gilead Sciences Inc. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.84
Reporting Date Feb 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.